Lv22
174 积分 2026-07-22 加入
Immunoscintigraphy with 99mTc-14F7 and 99mTc-Nimotuzumab in patients with non-small cell lung cancer
21小时前
已完结
Nab-paclitaxel versus solvent-based paclitaxel in patients with previously treated advanced gastric cancer (ABSOLUTE): an open-label, randomised, non-inferiority, phase 3 trial
10天前
已完结
PIK3CA mutational status and overall survival in patients with cervical cancer treated with radical chemoradiotherapy
14天前
已完结
PIK3CA Mutations and Their Impact on Survival Outcomes of Patients with Cervical Cancer: A Systematic Review
14天前
已完结
Genome Analysis of Latin American Cervical Cancer: Frequent Activation of the PIK3CA Pathway
14天前
已完结
Icotinib versus whole-brain irradiation in patients with EGFR -mutant non-small-cell lung cancer and multiple brain metastases (BRAIN): a multicentre, phase 3, open-label, parallel, randomised controlled trial
1个月前
已完结
Durvalumab versus placebo with chemoradiotherapy for locally advanced cervical cancer (CALLA): a randomised, double-blind, phase 3 trial
1个月前
已完结
Review for "Hyperprogressive Disease (HPD) in Solid Tumours Receiving Immune Checkpoint Inhibitors in a Real-World Setting"
1个月前
已关闭
Rechallenge with immune-checkpoint inhibitors in patients with advanced-stage lung cancer
1个月前
已完结
皖公网安备34019202002308
